Victory Pharma, Inc.

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals

Other Names/Subsidiaries

  • MiddleBrook Pharmaceuticals, Inc.
See more in Biomedtracker

Latest on Victory Pharma, Inc.

Pink Sheet

Post-Marketing Progress: Drug Industry Is Meeting Phase IV Commitments, FDA Says

 
• By Kate Rawson

FDA Office of New Drugs Director John Jenkins, MD, wants to correct what he says is a persistent “urban legend” about pharmaceutical regulation: that drug companies don’t complete most of their post-m

Pink Sheet

Egalet Lines Up Cash In Deal With Shionogi Ahead Of IPO

 
• By Jessica Merrill

Egalet Corp. has strengthened its cash position ahead of an IPO in a deal with Shionogi & Co. Ltd. announced Nov. 26. The Danish specialty pharma will receive $10 million upfront from its new Ja

Scrip

Egalet Lines Up Cash In Deal With Japan’s Shionogi Ahead Of IPO

 
• By Jessica Merrill

Egalet Corp. has strengthened its cash position ahead of an IPO in a deal with Shionogi & Co. Ltd. announced Nov. 26. The Danish specialty pharma will receive $10 million upfront from its new Ja

Pink Sheet

FDA’s Postmarketing Powers Force Shionogi To Withdraw Rybix ODT

 
• By Derrick Gingery

Shionogi Inc. plans to withdraw its pain medication Rybix ODT from the market immediately and stopped shipping existing product after FDA said it was not in compliance with one of the drug’s post-